(A) Freshly dissected Ephb4∆EC and littermate control hearts at 12 weeks of age. Heart weight and heart weight/tibia length index (HW/TL) ratio are increased in Ephb4∆EC mutants, whereas body weight …
Source data for Figure 1A,B,C,D.
(A–D) Immunohistochemistry on cross sections of hearts. Panels show the outer part of the wall of the left ventricle. (A) EphB4 is expressed in veins, venules (white arrowheads) and small …
Short axis view.
(A–C) Immunostaining of cross sections through 12 week-old control and Ephb4∆EC hearts. Confocal images show the outer (A, C) and inner part (B) of the left ventricle. (A) Vascular density, measured …
Source data for Figure 2A,B.
(A) TUNEL assay in Ephb4∆EC hearts. There is no detectable cell death in mutant ECs of the ventricular wall. (B) Hypoxia assay using Pimonidazole shows that Ephb4∆EC hearts are not hypoxic. Hearts …
(A) Immunohistochemistry on for Collagen I (ColI, green) and Collagen IV (ColIV, green) in transverse sections of control and Ephb4∆EC heart showing both ventricles. Arrowheads mark normal signal. …
(A–C) Electron micrographs show details of the ventricular wall of the left ventricle. (A) Mutant endothelial cells are thickened and present irregular lining (arrowheads). (B) Accumulation of …
Source data for Figure 2—figure supplement 3C.
(A) Efnb2∆EC and littermate control hearts at 12 weeks of age. Heart weight and heart weight/tibia length index (HW/TL) remain unaffected in Efnb2∆EC mutants. N = 6 for control and N = 5 for Efnb2∆EC…
Source data for Figure 3A,B,C,D.
(A) Control and Ephb4∆EC hearts at 10 weeks of age. Heart weight and heart weight/tibia length index (HW/TL) are unchanged in mutants. (B–D) Immunohistochemistry on cross sections of 12 week-old …
Source data for Figure 3—figure supplement 1A,B,C,D.
(A, B) Immunostaining on cross sections of the outer wall of the left ventricle. (A) Presence of microhemorrhages in the myocardium of Ephb4∆EC mice at 10 weeks. (B) Presence of Ter119+ red blood …
(A–D) Immunohistochemistry on longitudinal sections of control and Ephb4∆EC gastrocnemius at 12 weeks of age. (A) EphB4 and ephrin-B2 (GFP in Efnb2::GFP reporter line) are expressed in capillaries …
Source data for Figure 4B,C,D.
(A, B) Immunostaining on sections (150 µm thick) of the right kidney of 12 week-old Ephb4∆EC mutants and control littermates. No significant changes in kidney vasculature are visible after staining …
(A) Immunohistochemistry of lymphatic vessel in the intestinal mesentery. EphB4 immunosignal is lost in lymphatic vessels (arrowheads) but maintained in Ephb4∆LEC veins (arrows). (B) Control and …
(A–F) Global gene expression analysis of Ephb4∆EC ventricles by RNA sequencing at 12 weeks. (A) MA plot representing the 529 differentially expressed genes (p<0.05) including 268 upregulated genes …
RNA-seq analysis of Ephb4∆EC and control mouse heart ventricles.
The table indicates all the transcripts significantly upregulated and downregulated in Ephb4 mutant hearts.
Global proteome analysis of Ephb4∆EC and control mouse heart ventricles.
The table indicates all the proteins significantly upregulated and downregulated in Ephb4 mutant hearts.
(A–C) Global gene expression analysis of 12 week-old Ephb4∆EC ventricles by RNA sequencing. (A) Sample distance analysis of RNA-seq samples. N = 3 for controls and N = 3 for Ephb4∆EC. (B) TPM …
Source data for Figure 5—figure supplement 1B,C.
(A) Western blot analysis of lysates from cultured HUVECs stimulated with control human IgG/Fc (Ctrl Fc), human ephrin-B2/Fc (B2/Fc) or mouse EphB4/Fc (B4/Fc) (4 µg/ml, preclustered with 10µg/ml …
Source data for Figure 6B.
(A) Western blot analysis of HUVECs transfected with siControl, siEPHB4 or siCAV1, as indicated. Knockdown cells showed a reduction of CAV1 and pCAV1 protein levels. N = 3 for all treatments. (B) …
Source data for Figure 7C.
Source data for Figure 7E.
(A) Confocal images of siRNA-transfected HUVECs stained with CD36 (green), Golgi (GOLPH4, red), VE-Cadherin (CDH5, white) and nuclei (DAPI; blue). (B) Quantitation of CD36 signals localized to Golgi …
Source data for Figure 7—figure supplement 1B.
(A) Western blot analysis of CAV1 and pCAV1 levels in HUVECs stimulated with control human IgG/Fc (Ctrl Fc), ephrin-B2/Fc (B2/Fc) or EphB4/Fc (B4/Fc) (4 µg/ml, preclustered with 10µg/ml goat …
Source data for Figure 8B,F.
Source data for Figure 8D.
Source data for Figure 8E.
Source data for Figure 8G.
(A, B) Cell area quantitation of HUVECs transfected with siControl, siEPHB4 or siCAV1 (A) and HUVECs stimulated with control human IgG/Fc (Ctrl Fc), human ephrin-B2/Fc (B2/Fc) or mouse EphB4/Fc …
Source data for Figure 8—figure supplement 1A,B.
Source data for Figure 8—figure supplement 1C.
(A) Confocal images of HUVECs transfected siControl, siEPHB4 and siCAV1. Cells were fixed 30 min after exposure to BSA-555 (red) and immunostained with anti-CDH5 (white) antibody and DAPI (nuclei, …
Source data for Figure 9C.
(A, B) Flow cytometric analysis of Alexa Fluor 555 dye-conjugated bovine serum albumin (BSA-555) uptake by HUVECs transfected with siControl and siEPHB4 (A). N = 5 for both conditions. Data …
Source data for Figure 9—figure supplement 1A,C,F,G.
(A) Analysis of plasma from Ephb4∆EC mutants and control mice. Glucose concentration is reduced in mutants, whereas the concentrations of Triglycerides and Free fatty acids are unaltered. N = 4 for …
Source data for Figure 9—figure supplement 2A.
(A) Immunohistochemistry of cultured HUVECs. Relative colocalization of Vinculin and CDH5 is reduced in the cell contact area (arrowheads) of siEPHB4 cells. (B) Mechanical stress assay on cultured …
Source data for Figure 10C,D.
Key Resources Table.
List of all the materials and resources used.